Skip to main content
Premium Trial:

Request an Annual Quote

U. of Minnesota and Mayo Clinic Form State-Sponsored Biotech and Medical Genomics Partnership

NEW YORK, April 18 - With at least $72 million in funding from the state of Minnesota, The University of Minnesota and Mayo Clinic will embark on a multi-year biotechnology research partnership, Governor Tim Pawlenty of Minnesota said yesterday.


The initiative, called "Minnesota Partnership for Biotechnology and Medical Genomics," aims to promote joint research collaborations, initially in the areas of cancer, neurological disease, and heart disease.


Over the next two years, the state will provide $2 million in seed funding, matched by another $2 million from the university and Mayo Clinic. The state will finance an additional $70 million over five years to support research investments.


Moreover, the two institutions hope to raise money through a capital bonding proposal they plan to submit to the state this summer. This would be used to build a $30 million research center for genomics and bioinformatics on the Mayo Clinic campus in Rochester.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.